are glp-1 covered by insurance Costly Drugs Rarely for Weight Loss Marketplace Plans Poll: 1 in 8 Adults

Exendin-4 reverts behavioural and neurochemical dysfunction in a pre-motor rodent model of Parkinson's disease with noradrenergic deficit

See our take on this product and the evidence and safety of its ingredients

Metformin Improves Endothelial Function and Reduces Blood Pressure in Diabetic Spontaneously Hypertensive Rats Independent from GlycemiaControl: Comparison to Vildagliptin

GLP-1s have been rigorously studied since the Food and Drug Administration mandated safety trials in 2008

Optimizing the dose for individual goals Not every researcher needs or wants maximum weight loss

A growing body of research shows GLP-1 receptor agonists lower the risk of major cardiovascular events, including heart attacks and strokes, particularly in people with Type 2 diabetes